These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
61 related items for PubMed ID: 2288820
1. [Microalbuminuria, an early marker of renal changes in essential hypertension]. Cerasola G, Cottone S, D'Ignoto G, Fulantelli MA, Grasso L, Mangano MT, Marcellino T. Ann Ital Med Int; 1990; 5(3 Pt 1):180-5. PubMed ID: 2288820 [Abstract] [Full Text] [Related]
2. [Prevalence of microalbuminuria in recent-onset essential hypertension]. Cottone S, Contorno A, Nardi E, Zagarrigo C, Mangano MT, Panepinto N, Cerasola G. Cardiologia; 1993 Nov; 38(11):733-6. PubMed ID: 8004646 [Abstract] [Full Text] [Related]
3. Microalbuminuria fractional clearance and early renal permselectivity changes in essential hypertension. Cottone S, Cerasola G. Am J Nephrol; 1992 Nov; 12(5):326-9. PubMed ID: 1489001 [Abstract] [Full Text] [Related]
4. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Kato T, Horio T, Tomiyama M, Kamide K, Nakamura S, Yoshihara F, Nakata H, Nakahama H, Kawano Y. Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262 [Abstract] [Full Text] [Related]
5. Twelve shifting paradigms in diabetic renal disease and hypertension. Mogensen CE. Diabetes Res Clin Pract; 2008 Nov 13; 82 Suppl 1():S2-9. PubMed ID: 18947897 [Abstract] [Full Text] [Related]
6. Hypertension, microalbuminuria and renal dysfunction: the Renal Dysfunction in Hypertension (REDHY) study. Cerasola G, Mulè G, Cottone S, Nardi E, Cusimano P. J Nephrol; 2008 Nov 13; 21(3):368-73. PubMed ID: 18587725 [Abstract] [Full Text] [Related]
7. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. Cerasola G, Cottone S, Mulé G, Nardi E, Mangano MT, Andronico G, Contorno A, Li Vecchi M, Galione P, Renda F, Piazza G, Volpe V, Lisi A, Ferrara L, Panepinto N, Riccobene R. J Hypertens; 1996 Jul 13; 14(7):915-20. PubMed ID: 8818932 [Abstract] [Full Text] [Related]
8. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. Mulè G, Cottone S, Vadalà A, Volpe V, Mezzatesta G, Mongiovì R, Piazza G, Nardi E, Andronico G, Cerasola G. J Intern Med; 2004 Jul 13; 256(1):22-9. PubMed ID: 15189362 [Abstract] [Full Text] [Related]
9. Prediction of albuminuria by different blood pressure measurement methods in type 1 diabetes: a pilot study. Stergiou GS, Alamara C, Drakatos A, Stefanidis CJ, Vazeou A. Hypertens Res; 2009 Aug 13; 32(8):680-4. PubMed ID: 19498440 [Abstract] [Full Text] [Related]
10. Microalbuminuria in essential hypertension: clinical and biochemical profile. de la Sierra A, Bragulat E, Sierra C, Gomez-Angelats E, Antonio MT, Aguilera MT, Coca A. Br J Biomed Sci; 2000 Aug 13; 57(4):287-91. PubMed ID: 11204857 [Abstract] [Full Text] [Related]
11. Uric acid and nocturnal nondipping in hypertensive patients with normal renal function. Afsar B, Elsurer R, Ozdemir FN, Sezer S. J Nephrol; 2008 Aug 13; 21(3):406-11. PubMed ID: 18587730 [Abstract] [Full Text] [Related]
12. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS. J Hypertens; 1994 Aug 13; 12(8):947-53. PubMed ID: 7814854 [Abstract] [Full Text] [Related]
13. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Biesenbach G, Zazgornik J. Clin Nephrol; 1994 Apr 13; 41(4):211-8. PubMed ID: 8026113 [Abstract] [Full Text] [Related]
14. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria. Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group. Diabet Med; 2004 Nov 13; 21(11):1192-9. PubMed ID: 15498085 [Abstract] [Full Text] [Related]
15. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients. Feola M, Boffano GM, Procopio M, Reynaud S, Allemano P, Rizzi G. G Ital Cardiol; 1998 Jan 13; 28(1):38-44. PubMed ID: 9493044 [Abstract] [Full Text] [Related]
16. Microalbuminuria, blood pressure load, and systemic vascular permeability in primary hypertension. Viazzi F, Leoncini G, Ratto E, Vaccaro V, Tomolillo C, Falqui V, Parodi A, Conti N, Deferrari G, Pontremoli R. Am J Hypertens; 2006 Nov 13; 19(11):1183-9. PubMed ID: 17070433 [Abstract] [Full Text] [Related]
17. Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure. Jacobi J, Schlaich MP, Delles C, Schobel HP, Schmieder RE. Am J Hypertens; 1999 Apr 13; 12(4 Pt 1):418-22. PubMed ID: 10232503 [Abstract] [Full Text] [Related]
18. Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. Berrut G, Bouhanick B, Fabbri P, Guilloteau G, Bled F, Le Jeune JJ, Fressinaud P, Marre M. Clin Nephrol; 1997 Aug 13; 48(2):92-7. PubMed ID: 9285145 [Abstract] [Full Text] [Related]
19. [Possibilities of achieving target blood pressure in patients with essential hypertension in relation to renal functional status and age]. Dmitrova TB, Kotovskaia IuV, Kobalava ZhD, Moiseev VS. Ter Arkh; 2002 Aug 13; 74(12):29-33. PubMed ID: 12577836 [Abstract] [Full Text] [Related]
20. Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria. Eberhard OK, Kliem V, Offner G, Oldhafer K, Fangmann J, Pichlmay R, Koch KM, Brunkhorst R. Clin Transplant; 1997 Oct 13; 11(5 Pt 1):415-9. PubMed ID: 9361933 [Abstract] [Full Text] [Related] Page: [Next] [New Search]